| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| N-Acetyl Cysteine | Aortic Valve Stenosis | 1 | PM | 34619980 | 📋 | N-acetylcysteine inhibits aortic stenosis progression in a murine model by blocking shear-induced activation of platelet latent TGF-β1 |
| N-Acetyl Cysteine | Cardiac Arrest | 2 | PM | 35079634 | 📋 | Systemic administration of dendrimer N-acetyl cysteine improves outcomes and survival following cardiac arrest |
| N-Acetyl Cysteine | Cardiac Arrest | 1 | PM | 32782443 | 📋 | N-acetylcysteine alleviates post-resuscitation myocardial dysfunction and improves survival outcomes via partly inhibiting NLRP3 inflammasome induced-pyroptosis |
| N-Acetyl Cysteine | Cardiac Hypertrophy | 1 | PM | 37864839 | 📋 | N-acetylcysteine alleviates phenylephrine-induced cardiomyocyte dysfunction via engaging PI3K/AKT signaling pathway |
| N-Acetyl Cysteine | Cardiac Remodeling | 1 | PM | 36678548 | 📋 | Long-Term Sleep Deprivation-Induced Myocardial Remodeling and Mitochondrial Dysfunction in Mice Were Attenuated by Lipoic Acid and N-Acetylcysteine |
| N-Acetyl Cysteine | Cardiomyopathy | 1 | PM | 36139036 | 📋 | N-Acetylcysteine, an ROS Inhibitor, Alleviates the Pathophysiology of Hyperthyroidism-Induced Cardiomyopathy via the ROS/Ca2+ Pathway |
| N-Acetyl Cysteine | Diabetic Cardiomyopathy | 2 | PM | 37422055 | 📋 | N-acetylcysteine combined with insulin attenuates myocardial injury in canines with type 1 diabetes mellitus by modulating TNF-α-mediated apoptotic pathways and affecting linear ubiquitination |
| N-Acetyl Cysteine | Diabetic Cardiomyopathy | 1 | PM | 34885867 | 📋 | N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators |
| N-Acetyl Cysteine | Diabetic Cardiomyopathy | 3 | PM | 29174818 | 📋 | Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress |
| N-Acetyl Cysteine | Heart Failure | 2 | PM | 34727343 | 📋 | Oral N-acetylcysteine as an adjunct to standard medical therapy improved heart function in cases with stable class II and III systolic heart failure |
| N-Acetyl Cysteine | Heart Failure | 1 | PM | 33048324 | 📋 | Progression of heart failure is attenuated by antioxidant therapy with N-acetylcysteine in myocardial infarcted female rats |
| N-Acetyl Cysteine | Myocardial Infarction | 6 | PM | 33390565 | 📋 | The Clinical Efficacy of N-Acetylcysteine in the Treatment of ST Segment Elevation Myocardial Infarction |
| N-Acetyl Cysteine | Myocardial Infarction | 5 | PM | 33048324 | 📋 | Progression of heart failure is attenuated by antioxidant therapy with N-acetylcysteine in myocardial infarcted female rats |
| N-Acetyl Cysteine | Myocardial Infarction | 1 | PM | 32235559 | 📋 | Enhancing Glycolysis Protects Against Ischemia-Reperfusion Injury by Reducing ROS Production |
| N-Acetyl Cysteine | Myocardial Infarction | 2 | PM | 32041914 | 📋 | Effect of Oral N-Acetylcysteine Supplementation on the Immunity System in Patients With Acute Myocardial Infarction |
| N-Acetyl Cysteine | Myocardial Infarction | 4 | PM | 29623672 | 📋 | A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications |
| N-Acetyl Cysteine | Myocardial Infarction | 8 | PM | 22178923 | 📋 | Preventive effects of N-acetyl cysteine on lipids, lipoproteins and myocardial infarct size in isoproterenol induced myocardial infarcted rats: an in vivo and in vitro study |
| N-Acetyl Cysteine | Myocardial Infarction | 7 | PM | 21641783 | 📋 | An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats |
| N-Acetyl Cysteine | Myocardial Infarction | 3 | PM | 20664528 | 📋 | Cellular Antioxidant Levels Influence Muscle Stem Cell Therapy |
| N-Acetyl Cysteine | Myocardial Injury | 2 | PM | 34453856 | 📋 | Enhanced oxidative stress mediates pathological autophagy and necroptosis in cardiac myocytes in pressure overload induced heart failure in rats |
| N-Acetyl Cysteine | Myocardial Injury | 1 | PM | 33507837 | 📋 | N-acetyl cysteine can blunt metabolic and cardiovascular effects via down-regulation of cardiotrophin-1 in rat model of fructose-induced metabolic syndrome |
| N-Acetyl Cysteine | Myocardial Ischemia-Reperfusion | 5 | PM | 38647950 | 📋 | N-acetylcysteine Protects Against Myocardial Ischemia-Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice |
| N-Acetyl Cysteine | Myocardial Ischemia-Reperfusion | 4 | PM | 37054769 | 📋 | Acute administration of myeloid differentiation factor 2 inhibitor and N-acetyl cysteine attenuate brain damage in rats with cardiac ischemia/reperfusion injury |
| N-Acetyl Cysteine | Myocardial Ischemia-Reperfusion | 3 | PM | 34869660 | 📋 | N-Acetylcysteine for Cardiac Protection During Coronary Artery Reperfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| N-Acetyl Cysteine | Myocardial Ischemia-Reperfusion | 2 | PM | 32347295 | 📋 | Mechanism of N-acetylcysteine in Alleviating Diabetic Myocardial Ischemia Reperfusion Injury by Regulating PTEN/Akt Pathway Through Promoting DJ-1 |
| N-Acetyl Cysteine | Myocardial Ischemia-Reperfusion | 1 | PM | 32235559 | 📋 | Enhancing Glycolysis Protects Against Ischemia-Reperfusion Injury by Reducing ROS Production |
| N-Acetyl Cysteine | Myocarditis | 1 | PM | 31883926 | 📋 | N-Acetyl Cysteine Effectively Alleviates Coxsackievirus B-Induced Myocarditis Through Suppressing Viral Replication and Inflammatory Response |
